Sign In
Buy SYK
$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
2 Under-the-Radar Medtech Stocks to Buy Now
07:40am, Saturday, 05'th Nov 2022
Don't count out these discounted medical technology stocks.
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
08:05pm, Thursday, 03'rd Nov 2022 GlobeNewswire Inc.
Kalamazoo, Michigan, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
09:07am, Wednesday, 02'nd Nov 2022 Benzinga
Gainers
Abiomed, Inc. (NASDAQ: ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company . Also, the company reported better-than-expec
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
04:38pm, Tuesday, 01'st Nov 2022 Benzinga
Gainers
Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Abiomed, Inc. (NASDAQ: ABMD) shares jumped 50.4%
Stryker's (SYK) Q3 Earnings Miss Estimates, Volume Improves
03:55pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Stryker's (SYK) third-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
03:36pm, Tuesday, 01'st Nov 2022 Benzinga
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Varonis Systems, Inc. (NASDAQ: VRNS) shares tum
Where Stryker Stands With Analysts
03:04pm, Tuesday, 01'st Nov 2022 Benzinga
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
3
2
0
0
Last 30D
0
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
02:27pm, Tuesday, 01'st Nov 2022 Benzinga
Upgrades
For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to Buy. AnaptysBio earned $1.15 in the second quarter, compared to $0.02 in the year-ago quarter. The sto
Stryker's (SYK) Q3 Earnings Miss Estimates, Volume Improves
01:34pm, Tuesday, 01'st Nov 2022
Stryker's (SYK) third-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
Alibaba To $125? Plus This Analyst Slashes PT On Argo Blockchain By 90%
12:54pm, Tuesday, 01'st Nov 2022 Benzinga
Truist Securities slashed the price target on Alibaba Group Holding Limited (NYSE: BABA) from $135 to $125. Alibaba shares rose 6.5% to $67.70 in pre-market trading.
Cowen & Co. cut Carvana Co. (N
Why Goodyear Tire & Rubber Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
10:33am, Tuesday, 01'st Nov 2022 Benzinga
Gainers
Quotient Limited (NASDAQ: QTNT) rose 60.7% to $0.1295 in pre-market trading. Quotient shares dipped 37% on Monday after the company announced a 1-for-40 reverse stock split.
PhaseBio Pharmace
Stryker (SYK) Misses Q3 Earnings Estimates
09:25pm, Monday, 31'st Oct 2022 Zacks Investment Research
Stryker (SYK) delivered earnings and revenue surprises of -5.36% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Stryker Corporation (SYK) Q3 2022 Earnings Call Transcript
08:09pm, Monday, 31'st Oct 2022
Stryker Corporation (NYSE:SYK ) Q3 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Glenn Boehnlein - Chief Financial Offic
Stryker reports third quarter 2022 operating results
08:05pm, Monday, 31'st Oct 2022 GlobeNewswire Inc.
Kalamazoo, Michigan, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2022:
Stryker (SYK) Misses Q3 Earnings Estimates
06:50pm, Monday, 31'st Oct 2022
Stryker (SYK) delivered earnings and revenue surprises of -5.36% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
